National Cancer Institute (NCI)
NCI Public Inquiries Office
Building, 31, Room 10A03<br>31 Center Drive, MSC 2
Bethesda
Maryland
20892-2580
United States
Tel: 301-435-3848
Website: http://www.nci.nih.gov/
819 articles about National Cancer Institute (NCI)
-
VLP Therapeutics Announces Phase I SBIR Grant Award From NCI
10/12/2017
-
BioMarker Strategies Announces Phase I NCI Grant To Develop Companion Diagnostic To Identify Patients With Head And Neck Cancer Who Are Most Likely To Respond To Treatment With Cetuximab
10/4/2017
-
NCI Awards Grant To NuvOx Pharma For Phase II Clinical Trial In Brain Cancer
9/29/2017
-
NCI Selects Apexian Pharma To Participate In The SBIR Initiative Program
9/27/2017
-
Champions Oncology Announces $2 Million Award From The NCI To Develop And Evaluate Prostate Cancer PDX Models
9/26/2017
-
Soligenix Announces $1.5 Million NCI SBIR Grant Award Supporting The Pivotal Phase III Clinical Trial Of SGX301 For The Treatment Of Cutaneous T-Cell Lymphoma
9/18/2017
-
Aethlon Medical Receives NCI Contract Award
9/14/2017
-
BioMarker Strategies Announces Phase II NCI Grant To Continue Development Of Companion Diagnostic Test To Help Select Optimal Therapy For Patients With Non-Small Cell Lung Cancer
9/11/2017
-
SillaJen Announces Collaboration With The NCI For Development Of Combination Therapy With SillaJen's Pexastimogene Devacirepvec (Pexa-Vec) Oncolytic Immunotherapy
8/17/2017
-
Kite Pharma Highlights Publication From The NCI Demonstrating Responses In Patients With Metastatic Solid Tumors Treated With T Cell Receptor (TCR) Therapy Targeting MAGE A3
8/17/2017
-
TRACON Pharma Announces Positive Results From NCI Phase I/II Trial Of TRC105 And Nexavar In Hepatocellular Cancer Published In Clinical Cancer Research
8/16/2017
-
SignalRX Pharmaceuticals Awarded $2M Phase II STTR Grant From NCI For The Development Of Epigenetic-Kinase Inhibitors As Anticancer Agents
8/8/2017
-
Edico Genome Signs Contracts With National Human Genome Research Institute And NCI For Use Of DRAGEN For Cancer Research
8/2/2017
-
Adaptive Biotech Announces Translational Collaboration With NCI
7/26/2017
-
VolitionRX To Host A Conference Call Regarding A 13,500 Subject Colorectal Cancer Screening Trial With The Early Detection Research Network Of The U.S. NCI
7/20/2017
-
Volition America Announces A Colorectal Cancer Screening Trial Containing Approximately 13,500 Subjects In Collaboration With The Early Detection Research Network Of The U.S. NCI
7/18/2017
-
Cancer Prevention Pharma In Collaboration With The NCI And Vanderbilt University Medical Center Initiates Phase II Trial To Evaluate CPP-1X In Patients With High Risk Of Gastric Cancer
7/17/2017
-
Masonic Cancer Center, University of Minnesota Awarded NCI CURE Grant To Mentor Future Cancer Researchers
7/5/2017
-
Foundation Medicine, Inc. To Identify Patients Eligible For NCI’s NCI-Match (Molecular Analysis For Therapy Choice) Study
6/7/2017
-
Caris Life Sciences, NCI And ECOG-ACRIN Collaborate To Molecularly Identify Candidates For The NCI-MATCH Clinical Trial
6/7/2017